PharmPix CEO Martty Martínez Fraticelli Receives PBMI Award for Clinical Innovation
PharmPix President and CEO Dr. Martty Martínez Fraticelli has been honored with the PBMI Excellence Award for Clinical Innovation. The award recognizes his contributions to integrating clinical intelligence into pharmacy benefit decisions.

PharmPix President and CEO Dr. Martty Martínez Fraticelli has received the Pharmacy Benefit Management Institute (PBMI) Excellence Award for Clinical Innovation. The award acknowledges his strategic vision for incorporating clinical intelligence into decisions regarding pharmacy benefits.
Martínez Fraticelli's leadership at PharmPix has focused on enhancing the proactive management of costs and risks within the pharmacy benefit landscape. This recognition highlights his role in advancing industry practices by leveraging clinical insights to inform benefit strategies.
The PBMI Excellence Award is presented to individuals who demonstrate significant achievement and innovation in the field of pharmacy benefit management. It signifies a notable contribution to the sector's development and operational effectiveness.
PharmPix offers solutions aimed at improving the efficiency and accessibility of prescription drug therapies. The company continues to develop its offerings to address evolving needs within the healthcare system.